Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances.
about
Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Anthracycline cardiotoxicity in childhood.Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failureMind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Animal models in studies of cardiotoxicity side effects from antiblastic drugs in patients and occupational exposed workersRole of carnitine in cancer chemotherapy-induced multiple organ toxicity.Cardioprotective effect of methanolic extract of Ixora coccinea Linn. leaves on doxorubicin-induced cardiac toxicity in rats.Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats.Effects of molsidomine against doxorubicin-induced cardiotoxicity in rats.Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.Mangifera indica L. leaf extract alleviates doxorubicin induced cardiac stress.Synergistic effects of polydatin and vitamin C in inhibiting cardiotoxicity induced by doxorubicin in rats.Effect of valsartan on cardiac senescence and apoptosis in a rat model of cardiotoxicity.The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats
P2860
Q35989515-069D203A-ED1C-4E17-8C47-F004286B4F56Q36912561-578C54CD-F52B-4514-8298-FDAC2A6EF4BEQ37165394-308F08AE-BAB8-4B3B-B57E-30AC874255FFQ37373704-ADAD915B-A4BC-440B-B624-5BB5F9B5C6FAQ37467770-6734C957-D4E1-4714-AE50-9FFDD9B27993Q37631325-69453C53-7E15-476C-8863-C801D71711EEQ38130229-C38331DC-B522-4E94-8863-504D99B96461Q41882948-F5B4BADB-438B-406A-B27C-81C913617EEEQ42153380-5B1695A8-F67C-428E-9C0A-D46521D116FBQ44633014-69CB436B-104C-4FB7-B062-53CB14010BD9Q44961507-E704A41C-7B0D-49A9-B0A4-053ED2C681DBQ48402822-4FE20A18-72D5-433E-9DCA-C41A23DF1F57Q50144200-16800ACF-0A3F-4E9A-9BAB-96384AA6363CQ51092286-732CEBC3-9889-4876-95B3-D6375CAA67F2Q53148765-ABFAC4B7-952F-4421-BD70-6A2D77714105Q58787647-41CFBC28-B012-4C7F-885A-B30C06D399EC
P2860
Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@en
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@nl
type
label
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@en
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@nl
prefLabel
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@en
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@nl
P2093
P1476
Cardiotoxicity of doxorubicin: ...... ease of vasoactive substances.
@en
P2093
P2860
P304
P356
10.1111/J.1600-0773.1994.TB00330.X
P577
1994-08-01T00:00:00Z